Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) - Total Liabilities

Latest as of September 2025: CN¥3.56 Billion CNY ≈ $520.39 Million USD

Based on the latest financial reports, Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) has total liabilities worth CN¥3.56 Billion CNY (≈ $520.39 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 603707 cash flow conversion to assess how effectively this company generates cash.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd - Total Liabilities Trend (2013–2024)

This chart illustrates how Nanjing King-friend Biochemical Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Nanjing King-friend Biochemical Pharmace asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Nanjing King-friend Biochemical Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Empresas Cablevisión S.A.B. de C.V MX:CABLECPO	Mexico	MX$9.47 Billion
V2X Inc NYSE:VVX	USA	$2.10 Billion
Mtar Technologies Limited NSE:MTARTECH	India	Rs4.30 Billion
Triputra Agro Persada Tbk PT JK:TAPG	Indonesia	Rp3.01 Trillion
Partner TA:PTNR	Israel	ILA2.29 Billion
Aker Solutions ASA OL:AKSO	Norway	Nkr25.82 Billion
Ströer SE & Co. KGaA F:SAX	Germany	€2.39 Billion
Nanjing Hanrui Cobalt Co Ltd SHE:300618	China	CN¥3.55 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Nanjing King-friend Biochemical Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Nanjing King-friend Biochemical Pharmace (603707) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.46	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.53	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.35	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nanjing King-friend Biochemical Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nanjing King-friend Biochemical Pharmaceutical Co Ltd (2013–2024)

The table below shows the annual total liabilities of Nanjing King-friend Biochemical Pharmaceutical Co Ltd from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥3.02 Billion ≈ $442.18 Million	-18.89%
2023-12-31	CN¥3.73 Billion ≈ $545.20 Million	-3.05%
2022-12-31	CN¥3.84 Billion ≈ $562.34 Million	+36.56%
2021-12-31	CN¥2.81 Billion ≈ $411.80 Million	-29.22%
2020-12-31	CN¥3.98 Billion ≈ $581.78 Million	+91.67%
2019-12-31	CN¥2.07 Billion ≈ $303.54 Million	+111.40%
2018-12-31	CN¥981.21 Million ≈ $143.58 Million	+52.72%
2017-12-31	CN¥642.50 Million ≈ $94.02 Million	+208.75%
2016-12-31	CN¥208.09 Million ≈ $30.45 Million	+1.65%
2015-12-31	CN¥204.72 Million ≈ $29.96 Million	-59.72%
2014-12-31	CN¥508.26 Million ≈ $74.37 Million	+265.89%
2013-12-31	CN¥138.91 Million ≈ $20.33 Million	--

About Nanjing King-friend Biochemical Pharmaceutical Co Ltd

SHG:603707 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.15 Billion

CN¥14.70 Billion CNY

Market Cap Rank

#6068 Global

#1341 in China

Share Price

CN¥9.10

Change (1 day)

+0.00%

52-Week Range

CN¥9.03 - CN¥11.94

All Time High

CN¥33.62